Skip to main content

Advertisement

Log in

The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Many studies have reported the association between tumor necrosis factor-α (TNF-α)-238 polymorphism and digestive system cancer susceptibility, but the results were inconclusive. We performed a meta-analysis to derive a more precise estimation of the relationship between TNF-α-238 G/A polymorphism and digestive system cancer risk. Pooled analysis for the TNF-α-238 G/A polymorphism contained 26 studies with a total of 4849 cases and 8567 controls. The meta-analysis observed a significant association between TNF-α-238 G/A polymorphism and digestive system cancer risk in the overall population (GA vs GG: OR 1.19, 95 % CI 1.00–1.40, P heterpgeneity = 0.016; A vs G: OR 1.19, 95 % CI 1.03–1.39, P heterpgeneity = 0.015; dominant model: OR 1.20, 95 % CI 1.02–1.41, P heterpgeneity = 0.012). In the analysis of the ethnic subgroups, however, similar results were observed only in the Asian population, but not in the Caucasian population. Therefore, this meta-analysis suggests that TNF-α-238 G/A polymorphism is associated with a significantly increased risk of digestive system cancer. Further large and well-designed studies are needed to confirm these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Burn J, Mathers J, Bishop DT. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res. 2013;191:157–83.

    Article  CAS  PubMed  Google Scholar 

  3. Pellegrini ML, Argibay P, Gomez DE. Genetics and epigenetics of colorectal cancer. Acta Gastroenterol Latinoam. 2011;41(3):247–61.

    PubMed  Google Scholar 

  4. Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012;10(1):18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wang S, Liu Z, Wang L, et al. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009;6:327–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248:171–83.

    Article  CAS  PubMed  Google Scholar 

  8. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–6.

    Article  CAS  PubMed  Google Scholar 

  9. Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.

    Article  CAS  PubMed  Google Scholar 

  10. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1:3–19.

    Article  CAS  PubMed  Google Scholar 

  11. Gupta R, Sharma SC, Das SN. Association of TNF-α and TNFR1 promoters and 30 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol. 2008;44:455–63.

    Article  CAS  PubMed  Google Scholar 

  12. Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008;118:1395–9.

    Article  CAS  PubMed  Google Scholar 

  13. Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180–3.

    Article  CAS  PubMed  Google Scholar 

  14. Govan VA, Constant D, Hoffman M, et al. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphismin South African women with cervical cancer and control women. BMC Cancer. 2006;6:24.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nakajima K, Sasaki M, Nojima D, et al. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol. 2001;165:612–5.

    Article  CAS  PubMed  Google Scholar 

  16. Marsh HP, Haldar NA, Bunce M, et al. Polymorphisms in tumor necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumor at presentation. Br J Cancer. 2003;89:1096–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mestiri S, Bouaouina N, Ahmed SB, et al. Genetic variation in the tumor necrosis factoralpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer. 2001;91:672–8.

    Article  CAS  PubMed  Google Scholar 

  18. Shih CM, Lee YL, Chiou HL, et al. Association of TNFalpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.

    Article  PubMed  Google Scholar 

  19. Jung KW, Ha E, Yu GI, et al. TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta. 2009;407:16–9.

    Article  CAS  PubMed  Google Scholar 

  20. Chen X, Zhang L, Chang Y, et al. Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a Han Chinese population. Int J Biol Markers. 2011;26:181–7.

    Article  CAS  PubMed  Google Scholar 

  21. Jeng JE, Tsai HR, Chuang LY, et al. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore). 2009;88:349–57.

    Article  CAS  Google Scholar 

  22. Jang WH, Yang YI, Yea SS, et al. The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001;166:41–6.

    Article  CAS  PubMed  Google Scholar 

  23. Crusius JB, Canzian F, Capella G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894–902.

    Article  CAS  PubMed  Google Scholar 

  24. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer. 2003;104:617–23.

    Article  CAS  PubMed  Google Scholar 

  25. Garrity-Park MM, Loftus EV Jr, Bryant SC, Sandborn WJ, Smyrk TC. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol. 2008;103:407–15.

    Article  CAS  PubMed  Google Scholar 

  26. Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139:73–83.

    Article  CAS  PubMed  Google Scholar 

  27. Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol. 2004;4:314–20.

    Article  CAS  PubMed  Google Scholar 

  28. Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009;4:e5360.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Lindholm E, Bakhtadze E, Cilio C, et al. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One. 2008;3:e2546.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Shih CM, Lee YL, Chiou HL, et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 2006;52:15–20.

    Article  PubMed  Google Scholar 

  31. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–6.

    Article  CAS  PubMed  Google Scholar 

  32. Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine. 2005;29:141–52.

    Article  CAS  PubMed  Google Scholar 

  33. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammationrelated genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–25.

    Article  PubMed  Google Scholar 

  34. Yu JY, Li L, Ma H, Liu K, Cheng X, Li YL, Song XL. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumor Biol. 2013;34(6):3859–63.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Jiang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hui, M., Yan, X. & Jiang, Y. The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis. Clin Exp Med 16, 367–374 (2016). https://doi.org/10.1007/s10238-015-0363-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-015-0363-4

Keywords

Navigation